From July 2 to 6, 2025, Peijia Medical made a remarkable appearance at Beijing Valves with a range of innovative products covering aortic, mitral, and tricuspid valves, standing out as one of the most prominent Chinese innovators at the conference. 

 The company hosted a dedicated symposium on a dual-axis steerable valve system, where invited experts in TAVR engaged in in-depth discussions on the design features of the 3D dual-axis steerable TaurusMax system and its advantages in treating challenging anatomies such as horizontal hearts, bicuspid valves, and ascending aortic aneurysms. The session enhanced recognition of domestically developed technologies and promoted ongoing optimization of full-lifecycle TAVR patient management.

During the international/domestic live case broadcasts, Peijia Medical collaborated with top-tier centers in France, Switzerland, and China to demonstrate the procedural performance and immediate outcomes of the HighLife TSMVR system, MonarQ TTVR system, and TaurusTrio system in complex anatomies. These real-world cases made it tangible how innovative technologies address unmet clinical needs. 

Live Case of HighLife TSMVR System 

  For more information, please visit: https://mp.weixin.qq.com/s/pz1Qkybwl38pVXXZWzy-Cw https://mp.weixin.qq.com/s/5vT1cSGRK-sVZK-fBivdqg